MNK - ICPT MNK and TRMD are among pre market losers
2023-05-22 08:53:42 ET
- Rain Oncology ( RAIN ) +-82% Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma.
- Volcon ( VLCN ) +-30% slides after announcing new equity offering.
- Mallinckrodt ( MNK ) +-23% .
- Daxor Corporation ( DXR ) +-20% Announces Pricing of $4.0 Million Underwritten Public Offering.
- Intercept Pharmaceuticals ( ICPT ) +-14% .
- SunCar Technology Group ( SDA ) +-10% .
- The Vita Coco Company ( COCO ) +-10% Announces Secondary Offering of Common Stock by Selling Stockholder.
- Monogram Orthopaedics ( MGRM ) +-9% .
- ZIM Integrated Shipping Services ( ZIM ) +-9% to watch on Monday: Meta, Micron and more.
- Enveric Biosciences ( ENVB ) +-8% Announces Manuscript Detailing the Development of Novel Psilocin Prodrugs for the Treatment of Anxiety and Other Mental Health Disorders
- Lucy Scientific Discovery ( LSDI ) +-7% .
- Ironwood Pharmaceuticals ( IRWD ) +-7% falls 15% on deal to buy VectivBio for $17/share cash.
- Bioventus ( BVS ) +-6% .
- TORM ( TRMD ) +-6% .
- Global-e Online ( GLBE ) +-5% lower after posting Q1 results, updating guidance.
- Adamis Pharmaceuticals ( ADMP ) +-5% .
For further details see:
ICPT, MNK and TRMD are among pre market losers